ITeos Therapeutics Company
ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.
Investors
.jpg)
%20.jpg)
%20.jpg)
Funding Status:
IPO
Industry:
End-to-End Drug Development
Estimated Revenue:
$1M to $10M
Technology:
Biotechnology, Health Care, Medical
Headquarters:
Cambridge, Massachusetts, United States
Total Funding:
249739241.0
Last Funding Date:
2020-04-01
Last Funding Type:
Series B
Employee Number:
11-50
Investors Number:
17.0
Founded Date:
2011-01-01